Johnson & Johnson: ICOTYDE Ph3 2yr clinial PASI ~70% clear; Tecnis IOL optics = steady rev. HTA risk; market misprices - 15% rerate analysi. Track $JNJ at https://bsky.app/profile/bluestocks.app/feed/stock-jnj #finsky
Wall Street hits profit-powered peak. #finsky
